Colon cancer screening

Cancer Imaging

Volumn 2, Issue 1, 2001, Pages 10-14

  Heiken, Jay P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873448578     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2001.008     Document Type: Conference Paper

References (57)

1. Greenlee RT, Murray P, Bolden S, Wingo PA. Cancer statistics: 2000. CA Cancer J Clin 2000; 50: 7-33.
2. Bond JH. Screening guidelines for colorectal cancer. Am J Med 1999; 106(1A) 7S-10S: 75-105.
3. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997; 89: 1406-23.
4. Centers for Disease Control. Screening for colorectal cancer-United States, 1997. MMWR 1999; 48: 116-121.
5. Byers T, Levin B, Rothenberger D. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin 1997; 47: 154-60.
6. Winawer SJ, Fletcher RH, Miller L et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642.
7. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-71.
8. Kronborg O, Fenger C, Olsen J et al. Randomized study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71.
9. Hardcastle JD, Chamberlain JO, Robinson MHE et al. Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
10. Ederer F, Church TR, Mandel JS. Fecal occult blood screening in the Minnesota study: role of chance detection of lesions. J Natl Cancer Inst 1997; 89: 1423-8.
11. Ahlquist DA, Wieand HS, Moertel CG et al. Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and HemoQuant tests. JAMA 1993; 269: 1262-7.
12. Allison JE, Tekawa IS, Ransom LJ et al. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334: 155-9.
13. Selby JV, Friedman GD, Quesenberry CPJ et al. A casecontrol study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326: 653-7.
14. Newcomb PA, Norfleet RG, Storer BE et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84: 1572-5.
15. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy: a case-control study of 32 702 veterans. Ann Intern Med 1995; 123: 904-10.
16. Selby JV, Friedman GD. US preventative task force. Sigmoidoscopy in the periodic health examination of asymptomatic adults. JAMA 1989; 261: 594-601.
17. Selby JV, Friedman GD, Collen MF. Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiplastic Evaluation study. J Clin Epidemiol 1988; 41: 427-34.
18. Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991; 86: 1775-80.
19. Rex DK, Lehman GA, Hawes RH et al. Screening colonoscopy in symptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology 1991; 100: 64-7.
20. Kadakia SC, Wrobleski CS, Kadakia AS et al. Prevalence or proximal colonic polyps in average-risk asymptomatic patients with negative fecal occult blood test and flexible sigmoidoscopy. Gastrointest Endosc 1996; 44: 112-7.
21. Lemmel TG, Haseman JH, Rex DK et al. Neoplasia distal to the splenic flexure in patients with proximal colon cancer. Gastrointest Endosc 1996; 44: 109-11.
22. Imperiale TF, Wagner DR, Ching YL, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000; 343: 169-74.
23. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl JMed 1977; 329: 1977-81.
24. Jøgensen OD, Kronborg O, Fenger C. The Funen adenoma follow-up study: Incidence and death from colorectal carcinoma in an adenoma surveillance program. Scand J Gastroenterol 1993; 28: 869-74.
25. Rex DK. Colonoscopy: a review of its yield for cancer and adenomas by indication. Am J Gastroenterol 1995; 3: 353-65.
26. Godreau CJ. Office-based colonoscopy in a family practice. Fam Pract Res J 1992; 12: 313-20.
27. Jentschura D, Raute M, Winter J et al. Complications in endoscopy of the lower gastrointestinal tract: therapy and prognosis. Surg Endosc 1994; 8: 672-6.
28. Waye JD, Lewis BS, Yessayan S. Colonoscopy: a prospective report of complications. J Clin Gastroenterol 1992; 15: 347-51.
29. Bloomfield JA. Reliability of barium enema in detecting colonic neoplasia. Med J Austr 1981; 1: 631-3.
30. Jaramillo E, Slezak P. Comparison between double-contrast barium enema and colonoscopy to investigate lower gastrointestinal bleeding. Gastrointest Radiol 1992; 17: 81-3.
31. Brewster NT, Grieve DC, Saunders JH. Double-contrast barium enema and flexible sigmoidoscopy for routine colonic investigation. Br J Surg 1994; 8: 445-7.
32. Rex DK, Rahmani EY, Haseman JH et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997; 112: 17-23.
33. Fork FT, Lindstrom C, Ekelund G. Double contrast examination in carcinoma of the colon and rectum: a prospective clinical series. Acta Radiol 1983; 24: 177-88.
34. Johnson DC, Carlson HC, Taylor WE et al. Barium enema of carcinoma of the colon: sensitivity of double- and singlecontrast studies. Am J Radiol 1983; 140: 1143-9.
35. Fork FT. Double contrast enema and colonoscopy in polyp detection. Gut 1981; 22: 971-7.
36. Steine S, Stordahl A, Lunde OC et al. Double-contrast barium enema versus colonoscopy in the diagnosis of neoplastic disorders: aspects of decision-making in general practice. Fam Pract 1993; 10: 288-91.
37. Winawer SJ, Stewart ET, Zauber AG et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med 2000; 342: 1766-72.
38. Blakeborough A, Sheridan MB, Chapman AH. Complications of barium enema examinations: a survey of UK consultant radiologists 1992-1994. Clin Radiol 1992; 52: 142-8.
39. Hara AJ, Johnson CD, Reed JE et al. Detection of colorectal polyps with CT colography: initial assessment of sensitivity and specificity. Radiology 1997; 205: 59-65.
40. Fenlon HM, Nunes DP, Schroy PC et al. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med 1999; 341: 1496-503.
41. Kay CL, Kulling D, Hawes HR, Young JWR, Cotton PB. Virtual endoscopy -comparison with colonoscopy in the detection of space-occupying lesions of the colon. Endoscopy 2000; 32: 226-32.
42. Rex DK, Vining D, Kopecky KK. An initial experience with screening for colon polyps using spiral CT with and without CT colography (virtual colonoscopy). Gastrointest Endosc 1999; 50: 309-13.
43. Yee J, Akerkar GA, Hung RK et al. Colorectal neoplasia: performance characteristics of CT colonography for detection in 300 patients. Radiology 2001; 219: 685-92.
44. Callstrom MR, Johnson CD, Fletcher JG et al. CT colonography without cathartic preparation: feasibility study. Radiology 2001; 219: 693-8.
45. Eddy DM. Screening for colorectal cancer. Ann Intern Med 1990; 113: 373-84.
46. Glick S, Wagner JL, Johnson CD. Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer. Am J Radiol 1998; 170: 629-36.
47. Gyrd-Hansen D. Fecal occult blood tests: a cost-effectiveness analysis. Int J Technol Asses Health Care 1998; 14: 290-301.
48. Whynes DK, Nielson AR, Walker AR et al. Fecal occult blood screening for colorectal cancer: is it cost-effective? Health Econ 1998; 7: 21-9.
49. Garber AM, Phelps CE. Economic foundation of costeffectiveness analysis. J Health Econ 1997; 16: 1-31.
50. Brown ML, Fintor L. Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature. Breast Cancer Res Treat 1993; 25: 113-8.
51. Fuchs CS, Giovannucci EL, Colditz G. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994: 331: 1669-74.
52. Ahsan H, Neugut AI, Garbowski CG et al. Family history of colorectal adenomatous polyps and increased risk for colorectal cancer. Ann Intern Med 1998; 128: 900-5.
53. Winawer SJ, Zauber AG, Gerdes H et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 1996; 334: 82-7.
54. Ekbom A, Helmick C, Zack M et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228-33.
55. Ekbom A, Helmick C, Zack M et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990; 336: 357-9.
56. Vasen HF, Wijnen JT, Menko FH et al. Cancer risk in families with hereditary non-polyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996; 110: 1020-7.
57. Helm JF, Sandler RS. Colorectal cancer screening. Med Clin N Am 1999; 83: 1403-22. The digital object identifier for this article is: 10.1102/ 1470-7330.2001.008